Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Santyl vs. Bacitracin for Minor Partial Thickness Burns
NCT02673229Phase 4Terminated
- Sponsor
- University of Kansas Medical Center
- Start
- Sep 2013
- Primary completion
- Dec 2018
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of collagenase in burn injury (2 arms), sponsored by University of Kansas Medical Center. Primary endpoint: 95% Wound Healing at 21 days. Started Sep 2013; status: terminated.
02
Drugs
collagenase
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT02673229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02673229.